If the results were no good, you wouldnt expect them to go to the trouble of getting independent opinion......would u?
Also don't know why they would continue with "Progression of an oral version of ACV1 into formal preclinical development " if results of current testing were not positive.
Still has promise.....but as they say high risk.....should be high reward.
If the results were no good, you wouldnt expect them to go to...
Add to My Watchlist
What is My Watchlist?